Metal–organic frameworks as nanoplatforms for combination therapy in cancer treatment DOI
Zainab Lafi, Sina M. Matalqah,

Ebaa Abu-Saleem

и другие.

Medical Oncology, Год журнала: 2024, Номер 42(1)

Опубликована: Дек. 9, 2024

Язык: Английский

Microbial exopolysaccharides: Classification, biosynthetic pathway, industrial extraction and commercial production to unveil its bioprospection: A comprehensive review DOI

Juhi Kumari,

R.C. Kumawat,

Radha Prasanna

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер 297, С. 139917 - 139917

Опубликована: Янв. 15, 2025

Язык: Английский

Процитировано

0
A phytotherapeutic approach to hinder the resistance against clindamycin by MRSA: in vitro and in silico studies DOI Creative Commons
Amal Mayyas, Ali Al‐Samydai, Nehaya Al‐Karablieh

и другие.

Future Science OA, Год журнала: 2025, Номер 11(1)

Опубликована: Фев. 2, 2025

Aims This study investigates the potential effects of essential oils (EOs) in enhancing efficacy clindamycin against Methicillin-resistant Staphylococcus aureus (MRSA) using vitro and computer simulations. The research seeks to identify that exhibit synergistic activity with determine their key active components.

Язык: Английский

Процитировано

0
Design and synthesis of novel substituted s‐triazines tethered benzenesulfonamides as potential antimicrobial candidates: Antibiofilm and bacterial protein permeability assessments DOI Open Access
Ahmed A. Al‐Karmalawy, Haytham O. Tawfik, Gharieb S. El‐Sayyad

и другие.

Archiv der Pharmazie, Год журнала: 2025, Номер 358(3)

Опубликована: Март 1, 2025

Abstract New s ‐triazine hydrazone hybrids ( 4a – 4r ) were designed and synthesized as promising microbial DNA gyrase inhibitors. This was done by taking the lead inhibitor (AstraZeneca arylaminotriazine) a reference. The novel samples subsequently tested antimicrobial agents against certain pathogenic bacteria unicellular fungi. antibiofilm potential membrane leakage test used to determine mechanism of response. minimum inhibitory concentration (MIC) values 4g , 4i between 62.5 250.0 µg/mL. MIC for candidate Staphylococcus aureus, Candida albicans, Enterobacter agglomerans Klebsiella pneumonia are 62.5, 125.0, µg/mL, respectively. Conversely, compound µg/mL C. albicans E. 125.0 S. aureus K. . Besides, molecular docking study performed validate both binding affinity mode newly analogs candidates toward bacterial receptors. nanocomposites had potentials, which encouraging their use in biomedical applications. Consequently, afforded compounds can be employed future optimization.

Язык: Английский

Процитировано

0
Bacterial Diversity at Himalayan Pink Salt Extraction Site DOI Creative Commons

Yasmeen Malik,

Imran Ali, Ashif Sajjad

и другие.

Biology, Год журнала: 2025, Номер 14(3), С. 316 - 316

Опубликована: Март 20, 2025

Table salt, or sodium chloride, is extensively utilized in the culinary business as a flavoring agent, texture garnishing [...]

Язык: Английский

Процитировано

0
Metal–organic frameworks as nanoplatforms for combination therapy in cancer treatment DOI
Zainab Lafi, Sina M. Matalqah,

Ebaa Abu-Saleem

и другие.

Medical Oncology, Год журнала: 2024, Номер 42(1)

Опубликована: Дек. 9, 2024

Язык: Английский

Процитировано

3